Bokus

John T. Kemshead – författare

Visar alla böcker från författaren John T. Kemshead. Handla med fri frakt och snabb leverans.

4 produkter

  1. John T. Kemshead - Pediatric Tumors, Häftad. Tillgänglighet: Lägg i varukorg

    Pediatric Tumors

    Immunological and Molecular Markers

    Av John T. Kemshead

    Häftad, 2020

    1041 kr

    Lägg i varukorg

    This monograph explains the considerable impact that monoclonal antibodies and molecular probes have had on the diagnosis of tumor types and sub-types. It explains how radiolabelled monoclonal antibodies have also been used as imaging agents to try to improve the oncologist's ability to define …

  2. John T. Kemshead - Pediatric Tumors, Inbunden. Tillgänglighet: Lägg i varukorg

    Pediatric Tumors

    Immunological and Molecular Markers

    Av John T. Kemshead

    Inbunden, 1989

    7800 kr

    Lägg i varukorg

    This monograph explains the considerable impact that monoclonal antibodies and molecular probes have had on the diagnosis of tumor types and sub-types. It explains how radiolabelled monoclonal antibodies have also been used as imaging agents to try to improve the oncologist's ability to define …

  3. John T. Kemshead - Pediatric Tumors, E-bok. Tillgänglighet: Lägg i varukorg

    Pediatric Tumors

    Immunological and Molecular Markers

    Av John T. Kemshead

    E-bok, 2020

    1204 kr

    Lägg i varukorg

    This monograph explains the considerable impact that monoclonal antibodies and molecular probes have had on the diagnosis of tumor types and sub-types. It explains how radiolabelled monoclonal antibodies have also been used as imaging agents to try to improve the oncologist''s ability to define …

  4. John T. Kemshead - Pediatric Tumors, E-bok. Tillgänglighet: Lägg i varukorg

    Pediatric Tumors

    Immunological and Molecular Markers

    Av John T. Kemshead

    E-bok, 2020

    1231 kr

    Lägg i varukorg

    This monograph explains the considerable impact that monoclonal antibodies and molecular probes have had on the diagnosis of tumor types and sub-types. It explains how radiolabelled monoclonal antibodies have also been used as imaging agents to try to improve the oncologist''s ability to define …